The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 06, 2026 for Shankar Varadharajan
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 3.5 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Shankar Varadharajan has pledged 3,00,00,000 equity shares (about 4.63% of total share capital) of Fischer Medical Ventures in favour of HDFC Bank on February 5, 2026. The promoter holds 6,90,01,530 shares in total, representing 10.64% of the company, and had no shares encumbered before this event. After the pledge, 43.48% of his personal shareholding is now encumbered. The pledged shares are worth around Rs 109.59 crore, against a loan of Rs 40 crore, giving a comfortable security cover of 2.74 times. The loan is being used to fund the working capital needs of a wholly owned subsidiary of the group.
Short-term sentiment may be mildly negative as pledging promoter shares introduces the risk of forced selling if the loan defaults, though the 2.74x cover and the use of funds for group operations limit immediate concern. Shareholders should track the promoter's overall encumbrance level, which has now crossed the 20% of total share capital disclosure threshold.